Wegovy's active ingredient is semaglutide [1]. Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist [1].
What does semaglutide do in Wegovy?
Semaglutide works by mimicking the action of the natural hormone GLP-1 [1]. This hormone helps regulate blood sugar and also affects appetite [1]. Specifically, semaglutide binds to the GLP-1 receptor and activates it, which can lead to increased feelings of fullness and reduced hunger [1].
How is Wegovy administered?
Wegovy is administered as a subcutaneous injection [1].
What are the inactive ingredients in Wegovy?
The inactive ingredients in Wegovy are disodium phosphate dihydrate, propylene glycol, phenol, sodium hydroxide, and water for injection [1].
Can Wegovy be taken orally?
Wegovy is an injectable medication and is not available in an oral form [1]. Oral semaglutide is available under the brand name Rybelsus [2].
When does the Wegovy patent expire?
Patent information for Wegovy can be found on DrugPatentWatch.com [3]. The expiry dates for patents related to semaglutide and its formulations vary [3]. For example, some patents protecting semaglutide itself have later expiry dates than those covering specific formulations or methods of use [3].
Who manufactures Wegovy?
Wegovy is manufactured by Novo Nordisk [1].